Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2

This publication has 29 references indexed in Scilit:

• Immunotherapy of cancer using interleukin 2: current status and future prospects
  Immunology Today, 1988
• Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptors
  Cellular Immunology, 1988
• The regulatory effect of adherent cells on lymphokine activated killer cells
  Cellular Immunology, 1987
• Interleukin‐2 activated human killer lymphocytes: Lack of involvement of interferon in the development of IL‐2‐activated killer lymphocytes
  International Journal of Cancer, 1987
• Inhibition of adenylate cyclase by IL 2 in human T lymphocytes is mediated by protein kinase C
  Biochemical and Biophysical Research Communications, 1987
• Lymphokine-activated killer cells. Analysis of progenitors and effectors.
  The Journal of Experimental Medicine, 1986
• Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
  Science, 1983
• Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cells
  International Journal of Immunopharmacology, 1982
• Prostaglandin modulation of development of cell-mediated immunity in culture
  Nature, 1980
• Prostaglandins and the immune response
  Life Sciences, 1977